Ophthalmology · Boynton Beach, FL
NPI
1114116142
Since 2007
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
10075 S Jog Rd, Suite 203
Boynton Beach, FL, 33437
Phone (561) 767-9999
Groups this clinician bills Medicare through
Medicare paid, 2024
$565K
11,315 services
Medicare patients, 2024
400
Average age 77
Drug cost, 2024
$816K
3,354 prescriptions
Company payments, 2025
$1,920
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Deval D Joshi was code J2777 (injection, faricimab-svoa, 0.1 mg), 8,100 times for 23 patients. In total Deval D Joshi billed 11,315 services in 58 codes, and Medicare paid $565K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-04-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2777 Injection, faricimab-svoa, 0.1 mg | Office | 8,100 | 23 | $27.53 | $223K |
| 92134 Computerized Ophthalmic Imaging | Office | 529 | 214 | $31.48 | $17K |
| 92014 Ophthalmological E&M | Office | 360 | 264 | $91.80 | $33K |
| 92012 Ophthalmological E&M | Office | 255 | 157 | $68.63 | $18K |
| 67028 Intravitreal Injection | Office | 252 | 47 | $105.04 | $26K |
| 92004 Ophthalmological E&M | Office | 107 | 107 | $110.82 | $12K |
| 92250 Angiography | Office | 80 | 69 | $26.11 | $2,089 |
| 92083 Vision, Hearing, and Speech Services | Office | 73 | 66 | $47.50 | $3,467 |
| J7999 Compounded drug, not otherwise classified | Office | 64 | 15 | $62.10 | $3,975 |
| 92133 Computerized Ophthalmic Imaging | Office | 56 | 55 | $25.99 | $1,455 |
| 92136 Ultrasound - Nonspecific | Office | 52 | 39 | $31.65 | $1,646 |
| 66984 Cataract Surgery | Facility | 33 | 24 | $460.18 | $15K |
| 76514 Ultrasound - Nonspecific | Office | 24 | 23 | $8.59 | $206 |
| 67210 Eye | Office | 23 | 11 | $416.63 | $9,583 |
| 99212 Office E&M - Established | Office | 22 | 20 | $49.24 | $1,083 |
By year: 2022 $331K for 2,667 services; 2023 $428K for 6,011 services; 2024 $565K for 11,315 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83861 Clinical Chemistry | 32 | 13 | $22.23 | $711 |
Medicare prescription drug claims, 2024
In 2024, the drug Deval D Joshi prescribed most often to Medicare patients was Latanoprost, with 659 prescriptions and refills. In total Deval D Joshi wrote 3,354 Medicare prescriptions that cost $816K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 659 | 1,257 | 208 | $6,253 |
| Prednisolone Acetate Generic | 460 | 624 | 263 | $23K |
| Timolol Maleate Generic | 321 | 662 | 109 | $5,650 |
| Ofloxacin Generic | 256 | 258 | 181 | $2,686 |
| Ketorolac Tromethamine Generic | 225 | 243 | 146 | $3,535 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 192 | 382 | 66 | $2,912 |
| Brimonidine Tartrate Generic | 136 | 256 | 50 | $1,422 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 128 | 134 | 97 | $1,321 |
| Vabysmo Faricimab-Svoa | 97 | 100 | 18 | $275K |
| Combigan Brimonidine Tartrate/Timolol | 69 | 112 | 20 | $22K |
| Dorzolamide Hcl Generic | 67 | 125 | 30 | $1,336 |
| Eylea Aflibercept | 66 | 66 | 19 | $166K |
| Restasis Cyclosporine | 64 | 122 | 25 | $73K |
| Rhopressa Netarsudil Mesylate | 62 | 83 | 23 | $23K |
| Lumigan Bimatoprost | 61 | 83 | 15 | $21K |
Brand drugs: 1,339 claims; generic drugs: 2,015 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Deval D Joshi $1,920 ($1,920 in general payments such as food, travel and fees) from 14 companies. The largest payer was New World Medical,Inc. with $440.
| Company | Payments | Amount |
|---|---|---|
| New World Medical,Inc. | 7 | $440 |
| Genentech USA, Inc. ROG.SW | 4 | $227 |
| Abbvie Inc. ABBV | 4 | $220 |
| Harrow Eye, LLC | 5 | $216 |
| Astellas Pharma US Inc 4503.T | 4 | $184 |
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $154 |
| Carl Zeiss Meditec USA, Inc. | 1 | $139 |
| ANI Pharmaceuticals, Inc. ANIP | 5 | $111 |
| Apellis Pharmaceuticals, Inc. APLS | 3 | $83.59 |
| Bausch & Lomb Americas Inc. BLCO | 2 | $41.69 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.